Maryland to receive $15.5M from Glaxo over drug ads

Maryland has recovered $15 million from drug maker GlaxoSmithKline LLC to resolve allegations that the company engaged in improper marketing of the prescription drugs Avandia, Avandamet and Avandaryl, all of which are used to treat diabetes.

Leave a Reply

Your email address will not be published. Required fields are marked *